CN101401869A - Medicine prescription for activating blood and resolving stasis and treating hyperosteogeny - Google Patents
Medicine prescription for activating blood and resolving stasis and treating hyperosteogeny Download PDFInfo
- Publication number
- CN101401869A CN101401869A CNA2008102346780A CN200810234678A CN101401869A CN 101401869 A CN101401869 A CN 101401869A CN A2008102346780 A CNA2008102346780 A CN A2008102346780A CN 200810234678 A CN200810234678 A CN 200810234678A CN 101401869 A CN101401869 A CN 101401869A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- blood
- hyperosteogeny
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine formulation, in particular to a medicine formulation for treating hyperosteogeny by promoting blood circulation and removing blood stasis, The formulation has the functions of increasing cerebrovascular flow, reducing vascular resistance, improving cerebral blood supply and microcirculation, expanding blood vessels and arteriole, reducing blood viscosity, preventing thrombosis and dissolving thrombus for treating hyperosteogeny, in particular cervical vertebra hyperosteogeny; and can obviously improve dysfunction caused by ischemia. The medicine of the formulation can be taken orally or externally used. If people soak feet in the medicine decocted with water every day, the efficacy can be more remarkable.
Description
Technical field
The present invention relates to the medicine composition of a kind of Chinese medicine preparation, particularly a kind of activating blood and resolving stasis and treating hyperosteogeny.
Background technology
At present, along with socioeconomic fast development, people's work, rhythm of life are accelerated, and the universal people of making of computer bend over one's desk working often, make the hyperosteogeny illness perplex young crowd.The treatment hyperosteogeny disease is an a kind of difficult problem of medical science, adopts western medicine mostly, though it is very fast to take effect, but can only respite, needs of patients is taken for a long time, just can control disease, can't fundamentally remove slight illness, and the toxic and side effects of Western medicine is bigger, expenses for medicine is also relatively more expensive, and another kind of method is to use the traction method, and therapeutic process is relatively more painful, the patient is difficult for accepting, and does not have good solution so far.Bring very big burden to patient's life, patient's physical and mental health in serious threat.
Summary of the invention
The objective of the invention is to overcome above-mentioned the deficiencies in the prior art part, provide a kind of medicine composition of activating blood and resolving stasis and treating hyperosteogeny, for the hyperosteogeny of the treatment of hyperosteogeny, particularly cervical vertebra, the increase cerebrovascular flow is arranged, reduce vascular resistance, improve cerebral blood supply, microcirculation improvement, blood vessel dilating and arteriole, can reduce blood viscosity, the effect of anti-bolt and thrombolytic can also obviously improve the dysfunction that ischemia causes.
The objective of the invention is to realize with following technical scheme; (1) component of the present invention is: Radix Angelicae Sinensis, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Herba Lycopodii, Flos Carthami, Radix Scutellariae, Herba Pogostemonis, Cortex Phellodendri, Cortex Albiziae, Rhizoma Chuanxiong, Radix Achyranthis Bidentatae, Radix Salviae Miltiorrhizae, Radix Puerariae, Pericarpium Citri Reticulatae;
(2) main component weight portion of the present invention is: Radix Angelicae Sinensis 15-20 part Radix Paeoniae Rubra 15-20 part Radix Paeoniae Alba 15-20 part Herba Lycopodii 20-30 part Flos Carthami 15-20 part Radix Scutellariae 15-20 part Herba Pogostemonis 20-30 part Cortex Phellodendri 15-20 part Cortex Albiziae 15-20 part Rhizoma Chuanxiong 15-20 part Radix Achyranthis Bidentatae 15-20 part Radix Salviae Miltiorrhizae 20-30 part Radix Puerariae 15-20 part Pericarpium Citri Reticulatae 10-15 part.
We are activating blood circulation to dissipate blood stasis, promoting the flow of QI in the collateral by warming the meridian, enriching yin and nourishing kidney, wind-expelling pain-stopping.Rhizoma Chuanxiong and blood vessels are with wind dispelling, and Rhizoma Chuanxiong is joined Radix Angelicae Sinensis, nourshing blood and promoting blood circulation; The Rhizoma Chuanxiong property and flavor of peppery and warm, effect blood-activating and qi-promoting, wind-expelling pain-stopping.Rhizoma Chuanxiong is a blood circulation and stasis-eliminating medicine commonly used, and ancients have saying of " headache must being used Rhizoma Chuanxiong ".Successive dynasties are a lot of about the argumentation of Rhizoma Chuanxiong treatment head illness, all regard it as guiding drug or the key medicine that must use.In the clinical diagnosis and treatment process, attempt on the basis of determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, reusing Rhizoma Chuanxiong and treat the blood stasis type brain disorder that obstinate difficulty heals, get very speed of effect, determined curative effect.Radix Salviae Miltiorrhizae has stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, the effect of the relieving restlessness that clears away heart-fire, and Radix Salviae Miltiorrhizae also has microcirculation improvement, antiplatelet gathering and thrombosis, and blood viscosity is descended, and these effects help improving blood circulation, strengthen hypoxia-bearing capability.
Advantage of the present invention be; The medicine composition of treatment hyperosteogeny is for the hyperosteogeny of the treatment of hyperosteogeny, particularly cervical vertebra, the increase cerebrovascular flow is arranged, reduce vascular resistance, improve cerebral blood supply, microcirculation improvement, blood vessel dilating and arteriole can reduce blood viscosity, the effect of anti-bolt and thrombolytic, can also obviously improve the dysfunction that ischemia causes, this side's medicine oral administration, but also external, fry in shallow oil blister foot with medicine every day, and effect is more remarkable.
The invention will be further described below in conjunction with embodiment;
The specific embodiment
Embodiment 1.
(1) component of the present invention is: Radix Angelicae Sinensis, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Herba Lycopodii, Flos Carthami, Radix Scutellariae, Herba Pogostemonis, Cortex Phellodendri, Cortex Albiziae, Rhizoma Chuanxiong, Radix Achyranthis Bidentatae, Radix Salviae Miltiorrhizae, Radix Puerariae, Pericarpium Citri Reticulatae;
(2) main component weight portion of the present invention is: 10 parts of 15 parts of Pericarpium Citri Reticulataes of 20 parts of Radix Puerariaes of 15 parts of Radix Salviae Miltiorrhizaes of 15 parts of Radix Achyranthis Bidentataes of 15 parts of Rhizoma Chuanxiongs of 15 portions of Cortex Albiziaes of 20 portions of Cortex Phellodendris of 15 portions of Herba Pogostemoniss of 15 parts of Radix Scutellariaes of 20 parts of Flos Carthamis of 15 parts of Herba Lycopodiis of 15 portions of Radix Paeoniae Albas of 15 parts of Radix Paeoniae Rubra of Radix Angelicae Sinensis.
Embodiment 2.
(1) component of the present invention is: Radix Angelicae Sinensis, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Herba Lycopodii, Flos Carthami, Radix Scutellariae, Herba Pogostemonis, Cortex Phellodendri, Cortex Albiziae, Rhizoma Chuanxiong, Radix Achyranthis Bidentatae, Radix Salviae Miltiorrhizae, Radix Puerariae, Pericarpium Citri Reticulatae;
(2) main component weight portion of the present invention is: 15 parts of 20 parts of Pericarpium Citri Reticulataes of 30 parts of Radix Puerariaes of 20 parts of Radix Salviae Miltiorrhizaes of 20 parts of Radix Achyranthis Bidentataes of 20 parts of Rhizoma Chuanxiongs of 20 portions of Cortex Albiziaes of 30 portions of Cortex Phellodendris of 20 portions of Herba Pogostemoniss of 20 parts of Radix Scutellariaes of 30 parts of Flos Carthamis of 20 parts of Herba Lycopodiis of 20 portions of Radix Paeoniae Albas of 20 parts of Radix Paeoniae Rubra of Radix Angelicae Sinensis.
Claims (1)
1. the medicine composition of an activating blood and resolving stasis and treating hyperosteogeny is characterized in that:
(1) component of the present invention is: Radix Angelicae Sinensis, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Herba Lycopodii, Flos Carthami, Radix Scutellariae, Herba Pogostemonis, Cortex Phellodendri, Cortex Albiziae, Rhizoma Chuanxiong, Radix Achyranthis Bidentatae, Radix Salviae Miltiorrhizae, Radix Puerariae, Pericarpium Citri Reticulatae;
(2) main component weight portion of the present invention is:
Radix Angelicae Sinensis 15-20 part Radix Paeoniae Rubra 15-20 part Radix Paeoniae Alba 15-20 part Herba Lycopodii 20-30 part
Flos Carthami 15-20 part Radix Scutellariae 15-20 part Herba Pogostemonis 20-30 part Cortex Phellodendri 15-20 part
Cortex Albiziae 15-20 part Rhizoma Chuanxiong 15-20 part Radix Achyranthis Bidentatae 15-20 part Radix Salviae Miltiorrhizae 20-30 part
Radix Puerariae 15-20 part Pericarpium Citri Reticulatae 10-15 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008102346780A CN101401869A (en) | 2008-10-27 | 2008-10-27 | Medicine prescription for activating blood and resolving stasis and treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008102346780A CN101401869A (en) | 2008-10-27 | 2008-10-27 | Medicine prescription for activating blood and resolving stasis and treating hyperosteogeny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101401869A true CN101401869A (en) | 2009-04-08 |
Family
ID=40536118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008102346780A Pending CN101401869A (en) | 2008-10-27 | 2008-10-27 | Medicine prescription for activating blood and resolving stasis and treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101401869A (en) |
-
2008
- 2008-10-27 CN CNA2008102346780A patent/CN101401869A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463349B (en) | Traditional Chinese medicine composition for treating acute lumbar sprain | |
| CN102935153A (en) | Qi reinforcing qianzheng pills for cerebral thrombosis disease treatment | |
| CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN104491675A (en) | Soup capable of promoting blood circulation to remove blood stasis | |
| CN102274385B (en) | Medicament for treating nasosinusitis and preparation method thereof | |
| CN101513470B (en) | Chinese patent medicine for treating cervical vertebra disease | |
| CN103356953B (en) | A kind of Chinese medicine composition for the treatment of lumbar muscle strain | |
| CN100512840C (en) | Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis | |
| CN104587225A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN104645078A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN103550356B (en) | Traditional Chinese medicinal composition for treating thrombus | |
| CN102423354B (en) | Traditional Chinese medicine for treating hypertension | |
| CN105617042A (en) | Traditional Chinese medicine composition for treating headache | |
| CN101401906A (en) | Anshen oral liquid for treating aypnia | |
| CN101401869A (en) | Medicine prescription for activating blood and resolving stasis and treating hyperosteogeny | |
| CN100493558C (en) | Oral liquid for apoplexy | |
| CN101450135A (en) | Foot-bath medicine formula for treating hyperosteogeny | |
| CN103611079A (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
| CN101757329B (en) | Traditional Chinese medicine thrombolysis capsule for treating cerebral thrombosis | |
| CN105213989A (en) | A kind of Chinese medicine decoction for the treatment of phlegm resistance pattern of syndrome cranial tinnitus | |
| CN103083613A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN101244209B (en) | Medicament for preventing or treating cardiovascular and cerebrovascular diseases | |
| CN105213985A (en) | A kind of Chinese medicine decoction for the treatment of syndrome of marrow depletion due to kidney deficiency type cranial tinnitus | |
| CN105213880A (en) | A kind of Chinese medicine composition for the treatment of Liver and kidney void initiation cerebral blood supply insufficiency | |
| CN104784358A (en) | Traditional Chinese medicine for treating migraine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090408 |